ID   RPC1_HUMAN              Reviewed;        1390 AA.
AC   O14802; Q8IW34; Q8TCW5;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   23-SEP-2008, sequence version 2.
DT   15-MAR-2017, entry version 154.
DE   RecName: Full=DNA-directed RNA polymerase III subunit RPC1;
DE            Short=RNA polymerase III subunit C1;
DE            EC=2.7.7.6;
DE   AltName: Full=DNA-directed RNA polymerase III largest subunit;
DE   AltName: Full=DNA-directed RNA polymerase III subunit A;
DE   AltName: Full=RNA polymerase III 155 kDa subunit;
DE            Short=RPC155;
DE   AltName: Full=RNA polymerase III subunit C160;
GN   Name=POLR3A;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=9331371;
RA   Sepehri S., Hernandez N.;
RT   "The largest subunit of human RNA polymerase III is closely related to
RT   the largest subunit of yeast and trypanosome RNA polymerase III.";
RL   Genome Res. 7:1006-1019(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-374.
RX   PubMed=12384934; DOI=10.1002/art.10521;
RA   Kuwana M., Kimura K., Kawakami Y.;
RT   "Identification of an immunodominant epitope on RNA polymerase III
RT   recognized by systemic sclerosis sera: application to enzyme-linked
RT   immunosorbent assay.";
RL   Arthritis Rheum. 46:2742-2747(2002).
RN   [6]
RP   IDENTIFICATION IN THE RNA POL III COMPLEX, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=12391170; DOI=10.1128/MCB.22.22.8044-8055.2002;
RA   Hu P., Wu S., Sun Y., Yuan C.-C., Kobayashi R., Myers M.P.,
RA   Hernandez N.;
RT   "Characterization of human RNA polymerase III identifies orthologues
RT   for Saccharomyces cerevisiae RNA polymerase III subunits.";
RL   Mol. Cell. Biol. 22:8044-8055(2002).
RN   [7]
RP   FUNCTION.
RX   PubMed=19631370; DOI=10.1016/j.cell.2009.06.015;
RA   Chiu Y.-H., Macmillan J.B., Chen Z.J.;
RT   "RNA polymerase III detects cytosolic DNA and induces type I
RT   interferons through the RIG-I pathway.";
RL   Cell 138:576-591(2009).
RN   [8]
RP   FUNCTION.
RX   PubMed=19609254; DOI=10.1038/ni.1779;
RA   Ablasser A., Bauernfeind F., Hartmann G., Latz E., Fitzgerald K.A.,
RA   Hornung V.;
RT   "RIG-I-dependent sensing of poly(dA:dT) through the induction of an
RT   RNA polymerase III-transcribed RNA intermediate.";
RL   Nat. Immunol. 10:1065-1072(2009).
RN   [9]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-445, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   VARIANTS HLD7 ASN-372; LEU-558; TYR-636; GLU-672; TYR-724; ILE-775;
RP   VAL-852 AND THR-1247 INS, INVOLVEMENT IN HLD7, AND TISSUE SPECIFICITY.
RX   PubMed=21855841; DOI=10.1016/j.ajhg.2011.07.014;
RA   Bernard G., Chouery E., Putorti M.L., Tetreault M., Takanohashi A.,
RA   Carosso G., Clement I., Boespflug-Tanguy O., Rodriguez D., Delague V.,
RA   Abou Ghoch J., Jalkh N., Dorboz I., Fribourg S., Teichmann M.,
RA   Megarbane A., Schiffmann R., Vanderver A., Brais B.;
RT   "Mutations of POLR3A encoding a catalytic subunit of RNA polymerase
RT   Pol III cause a recessive hypomyelinating leukodystrophy.";
RL   Am. J. Hum. Genet. 89:415-423(2011).
RN   [12]
RP   VARIANTS HLD7 ASN-897 AND CYS-1005.
RX   PubMed=22036171; DOI=10.1016/j.ajhg.2011.10.003;
RA   Saitsu H., Osaka H., Sasaki M., Takanashi J., Hamada K., Yamashita A.,
RA   Shibayama H., Shiina M., Kondo Y., Nishiyama K., Tsurusaki Y.,
RA   Miyake N., Doi H., Ogata K., Inoue K., Matsumoto N.;
RT   "Mutations in POLR3A and POLR3B encoding RNA Polymerase III subunits
RT   cause an autosomal-recessive hypomyelinating leukoencephalopathy.";
RL   Am. J. Hum. Genet. 89:644-651(2011).
RN   [13]
RP   VARIANTS HLD7 LEU-91; GLY-387; ARG-602; VAL-852; CYS-1005 AND
RP   LYS-1261.
RX   PubMed=23355746; DOI=10.1136/jmedgenet-2012-101357;
RA   Daoud H., Tetreault M., Gibson W., Guerrero K., Cohen A.,
RA   Gburek-Augustat J., Synofzik M., Brais B., Stevens C.A.,
RA   Sanchez-Carpintero R., Goizet C., Naidu S., Vanderver A., Bernard G.;
RT   "Mutations in POLR3A and POLR3B are a major cause of hypomyelinating
RT   leukodystrophies with or without dental abnormalities and/or
RT   hypogonadotropic hypogonadism.";
RL   J. Med. Genet. 50:194-197(2013).
RN   [14]
RP   VARIANTS HLD7 CYS-310 AND THR-804.
RX   PubMed=23694757; DOI=10.1016/j.braindev.2013.04.011;
RA   Shimojima K., Shimada S., Tamasaki A., Akaboshi S., Komoike Y.,
RA   Saito A., Furukawa T., Yamamoto T.;
RT   "Novel compound heterozygous mutations of POLR3A revealed by whole-
RT   exome sequencing in a patient with hypomyelination.";
RL   Brain Dev. 36:315-321(2014).
CC   -!- FUNCTION: DNA-dependent RNA polymerase catalyzes the transcription
CC       of DNA into RNA using the four ribonucleoside triphosphates as
CC       substrates. Largest and catalytic core component of RNA polymerase
CC       III which synthesizes small RNAs, such as 5S rRNA and tRNAs. Forms
CC       the polymerase active center together with the second largest
CC       subunit. A single-stranded DNA template strand of the promoter is
CC       positioned within the central active site cleft of Pol III. A
CC       bridging helix emanates from RPC1 and crosses the cleft near the
CC       catalytic site and is thought to promote translocation of Pol III
CC       by acting as a ratchet that moves the RNA-DNA hybrid through the
CC       active site by switching from straight to bent conformations at
CC       each step of nucleotide addition (By similarity). Plays a key role
CC       in sensing and limiting infection by intracellular bacteria and
CC       DNA viruses. Acts as nuclear and cytosolic DNA sensor involved in
CC       innate immune response. Can sense non-self dsDNA that serves as
CC       template for transcription into dsRNA. The non-self RNA polymerase
CC       III transcripts, such as Epstein-Barr virus-encoded RNAs (EBERs)
CC       induce type I interferon and NF- Kappa-B through the RIG-I
CC       pathway. {ECO:0000250, ECO:0000269|PubMed:19609254,
CC       ECO:0000269|PubMed:19631370}.
CC   -!- CATALYTIC ACTIVITY: Nucleoside triphosphate + RNA(n) = diphosphate
CC       + RNA(n+1).
CC   -!- SUBUNIT: Component of the RNA polymerase III (Pol III) complex
CC       consisting of 17 subunits. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- TISSUE SPECIFICITY: Expressed in the brain, in the cortex and the
CC       white matter (at protein level). {ECO:0000269|PubMed:21855841}.
CC   -!- DISEASE: Leukodystrophy, hypomyelinating, 7, with or without
CC       oligodontia and/or hypogonadotropic hypogonadism (HLD7)
CC       [MIM:607694]: An autosomal recessive neurodegenerative disorder
CC       characterized by childhood onset of progressive motor decline
CC       manifest as spasticity, ataxia, tremor, and cerebellar signs, as
CC       well as mild cognitive regression. Other features may include
CC       hypodontia or oligodontia and hypogonadotropic hypogonadism. There
CC       is considerable inter- and intrafamilial variability.
CC       {ECO:0000269|PubMed:21855841, ECO:0000269|PubMed:22036171,
CC       ECO:0000269|PubMed:23355746, ECO:0000269|PubMed:23694757}.
CC       Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the RNA polymerase beta' chain family.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF021351; AAB86536.1; -; mRNA.
DR   EMBL; AL512628; CAI16466.1; -; Genomic_DNA.
DR   EMBL; CH471083; EAW54617.1; -; Genomic_DNA.
DR   EMBL; BC041089; AAH41089.1; -; mRNA.
DR   EMBL; AY091459; AAM12029.1; -; mRNA.
DR   CCDS; CCDS7354.1; -.
DR   RefSeq; NP_008986.2; NM_007055.3.
DR   UniGene; Hs.436896; -.
DR   ProteinModelPortal; O14802; -.
DR   BioGrid; 116301; 66.
DR   IntAct; O14802; 15.
DR   STRING; 9606.ENSP00000361446; -.
DR   iPTMnet; O14802; -.
DR   PhosphoSitePlus; O14802; -.
DR   BioMuta; POLR3A; -.
DR   EPD; O14802; -.
DR   MaxQB; O14802; -.
DR   PaxDb; O14802; -.
DR   PeptideAtlas; O14802; -.
DR   PRIDE; O14802; -.
DR   Ensembl; ENST00000372371; ENSP00000361446; ENSG00000148606.
DR   GeneID; 11128; -.
DR   KEGG; hsa:11128; -.
DR   UCSC; uc001jzn.4; human.
DR   CTD; 11128; -.
DR   DisGeNET; 11128; -.
DR   GeneCards; POLR3A; -.
DR   GeneReviews; POLR3A; -.
DR   HGNC; HGNC:30074; POLR3A.
DR   HPA; HPA037926; -.
DR   MalaCards; POLR3A; -.
DR   MIM; 607694; phenotype.
DR   MIM; 614258; gene.
DR   neXtProt; NX_O14802; -.
DR   OpenTargets; ENSG00000148606; -.
DR   Orphanet; 88637; Hypomyelination - hypogonadotropic hypogonadism - hypodontia.
DR   Orphanet; 77295; Odontoleukodystrophy.
DR   PharmGKB; PA134900426; -.
DR   eggNOG; KOG0260; Eukaryota.
DR   eggNOG; COG0086; LUCA.
DR   GeneTree; ENSGT00850000132392; -.
DR   HOGENOM; HOG000222974; -.
DR   HOVERGEN; HBG004339; -.
DR   InParanoid; O14802; -.
DR   KO; K03018; -.
DR   OMA; GEDLCAN; -.
DR   OrthoDB; EOG091G0FNO; -.
DR   PhylomeDB; O14802; -.
DR   TreeFam; TF103054; -.
DR   Reactome; R-HSA-1834949; Cytosolic sensors of pathogen-associated DNA.
DR   Reactome; R-HSA-73780; RNA Polymerase III Chain Elongation.
DR   Reactome; R-HSA-73980; RNA Polymerase III Transcription Termination.
DR   Reactome; R-HSA-749476; RNA Polymerase III Abortive And Retractive Initiation.
DR   Reactome; R-HSA-76061; RNA Polymerase III Transcription Initiation From Type 1 Promoter.
DR   Reactome; R-HSA-76066; RNA Polymerase III Transcription Initiation From Type 2 Promoter.
DR   Reactome; R-HSA-76071; RNA Polymerase III Transcription Initiation From Type 3 Promoter.
DR   ChiTaRS; POLR3A; human.
DR   GenomeRNAi; 11128; -.
DR   PRO; PR:O14802; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000148606; -.
DR   CleanEx; HS_POLR3A; -.
DR   ExpressionAtlas; O14802; baseline and differential.
DR   Genevisible; O14802; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005666; C:DNA-directed RNA polymerase III complex; IDA:MGI.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0003682; F:chromatin binding; IEA:Ensembl.
DR   GO; GO:0003677; F:DNA binding; IEA:InterPro.
DR   GO; GO:0003899; F:DNA-directed 5'-3' RNA polymerase activity; NAS:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0051607; P:defense response to virus; IEA:UniProtKB-KW.
DR   GO; GO:0045087; P:innate immune response; IMP:UniProtKB.
DR   GO; GO:0032728; P:positive regulation of interferon-beta production; IMP:UniProtKB.
DR   GO; GO:1903955; P:positive regulation of protein targeting to mitochondrion; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0032481; P:positive regulation of type I interferon production; TAS:Reactome.
DR   GO; GO:1903146; P:regulation of mitophagy; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0006383; P:transcription from RNA polymerase III promoter; IEA:GOC.
DR   GO; GO:0006351; P:transcription, DNA-templated; NAS:UniProtKB.
DR   InterPro; IPR000722; RNA_pol_asu.
DR   InterPro; IPR006592; RNA_pol_N.
DR   InterPro; IPR007080; RNA_pol_Rpb1_1.
DR   InterPro; IPR007066; RNA_pol_Rpb1_3.
DR   InterPro; IPR007083; RNA_pol_Rpb1_4.
DR   InterPro; IPR007081; RNA_pol_Rpb1_5.
DR   Pfam; PF04997; RNA_pol_Rpb1_1; 1.
DR   Pfam; PF00623; RNA_pol_Rpb1_2; 1.
DR   Pfam; PF04983; RNA_pol_Rpb1_3; 1.
DR   Pfam; PF05000; RNA_pol_Rpb1_4; 1.
DR   Pfam; PF04998; RNA_pol_Rpb1_5; 1.
DR   SMART; SM00663; RPOLA_N; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Antiviral defense; Complete proteome; Disease mutation;
KW   DNA-directed RNA polymerase; Immunity; Innate immunity;
KW   Leukodystrophy; Magnesium; Metal-binding; Nucleotidyltransferase;
KW   Nucleus; Polymorphism; Reference proteome; Transcription; Transferase;
KW   Zinc.
FT   CHAIN         1   1390       DNA-directed RNA polymerase III subunit
FT                                RPC1.
FT                                /FTId=PRO_0000073947.
FT   REGION      844    856       Bridging helix. {ECO:0000250}.
FT   METAL        69     69       Zinc 1. {ECO:0000250}.
FT   METAL        72     72       Zinc 1. {ECO:0000250}.
FT   METAL        79     79       Zinc 1. {ECO:0000250}.
FT   METAL        82     82       Zinc 1. {ECO:0000250}.
FT   METAL       109    109       Zinc 2. {ECO:0000250}.
FT   METAL       112    112       Zinc 2. {ECO:0000250}.
FT   METAL       156    156       Zinc 2. {ECO:0000250}.
FT   METAL       499    499       Magnesium; catalytic. {ECO:0000250}.
FT   METAL       501    501       Magnesium; catalytic. {ECO:0000250}.
FT   METAL       503    503       Magnesium; catalytic. {ECO:0000250}.
FT   MOD_RES     445    445       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   VARIANT      91     91       P -> L (in HLD7).
FT                                {ECO:0000269|PubMed:23355746}.
FT                                /FTId=VAR_072338.
FT   VARIANT     310    310       W -> C (in HLD7).
FT                                {ECO:0000269|PubMed:23694757}.
FT                                /FTId=VAR_072339.
FT   VARIANT     372    372       D -> N (in HLD7; dbSNP:rs267608673).
FT                                {ECO:0000269|PubMed:21855841}.
FT                                /FTId=VAR_066516.
FT   VARIANT     387    387       A -> G (in HLD7).
FT                                {ECO:0000269|PubMed:23355746}.
FT                                /FTId=VAR_072340.
FT   VARIANT     558    558       F -> L (in HLD7; dbSNP:rs267608668).
FT                                {ECO:0000269|PubMed:21855841}.
FT                                /FTId=VAR_066517.
FT   VARIANT     582    582       R -> L (in dbSNP:rs34588967).
FT                                /FTId=VAR_051873.
FT   VARIANT     602    602       S -> R (in HLD7; dbSNP:rs762708292).
FT                                {ECO:0000269|PubMed:23355746}.
FT                                /FTId=VAR_072341.
FT   VARIANT     636    636       S -> Y (in HLD7; dbSNP:rs267608676).
FT                                {ECO:0000269|PubMed:21855841}.
FT                                /FTId=VAR_066518.
FT   VARIANT     672    672       G -> E (in HLD7; dbSNP:rs267608670).
FT                                {ECO:0000269|PubMed:21855841}.
FT                                /FTId=VAR_066519.
FT   VARIANT     713    713       K -> N (in dbSNP:rs35354908).
FT                                /FTId=VAR_051874.
FT   VARIANT     724    724       C -> Y (in HLD7; dbSNP:rs267608679).
FT                                {ECO:0000269|PubMed:21855841}.
FT                                /FTId=VAR_066520.
FT   VARIANT     775    775       N -> I (in HLD7; dbSNP:rs267608672).
FT                                {ECO:0000269|PubMed:21855841}.
FT                                /FTId=VAR_066521.
FT   VARIANT     804    804       I -> T (in HLD7).
FT                                {ECO:0000269|PubMed:23694757}.
FT                                /FTId=VAR_072342.
FT   VARIANT     852    852       M -> V (in HLD7; dbSNP:rs267608671).
FT                                {ECO:0000269|PubMed:21855841,
FT                                ECO:0000269|PubMed:23355746}.
FT                                /FTId=VAR_066522.
FT   VARIANT     897    897       I -> N (in HLD7; dbSNP:rs267608681).
FT                                {ECO:0000269|PubMed:22036171}.
FT                                /FTId=VAR_067004.
FT   VARIANT    1005   1005       R -> C (in HLD7; dbSNP:rs267608682).
FT                                {ECO:0000269|PubMed:22036171,
FT                                ECO:0000269|PubMed:23355746}.
FT                                /FTId=VAR_066523.
FT   VARIANT    1247   1247       T -> TT (in HLD7).
FT                                {ECO:0000269|PubMed:21855841}.
FT                                /FTId=VAR_066524.
FT   VARIANT    1261   1261       E -> K (in HLD7; dbSNP:rs371703979).
FT                                {ECO:0000269|PubMed:23355746}.
FT                                /FTId=VAR_072343.
FT   CONFLICT     15     15       I -> T (in Ref. 1; AAB86536).
FT                                {ECO:0000305}.
FT   CONFLICT    262    262       I -> F (in Ref. 1; AAB86536).
FT                                {ECO:0000305}.
FT   CONFLICT    283    283       L -> P (in Ref. 5; AAM12029).
FT                                {ECO:0000305}.
FT   CONFLICT   1056   1056       A -> G (in Ref. 1; AAB86536).
FT                                {ECO:0000305}.
FT   CONFLICT   1275   1275       M -> MV (in Ref. 1; AAB86536).
FT                                {ECO:0000305}.
SQ   SEQUENCE   1390 AA;  155641 MW;  56F30900848E3DB9 CRC64;
     MVKEQFRETD VAKKISHICF GMKSPEEMRQ QAHIQVVSKN LYSQDNQHAP LLYGVLDHRM
     GTSEKDRPCE TCGKNLADCL GHYGYIDLEL PCFHVGYFRA VIGILQMICK TCCHIMLSQE
     EKKQFLDYLK RPGLTYLQKR GLKKKISDKC RKKNICHHCG AFNGTVKKCG LLKIIHEKYK
     TNKKVVDPIV SNFLQSFETA IEHNKEVEPL LGRAQENLNP LVVLNLFKRI PAEDVPLLLM
     NPEAGKPSDL ILTRLLVPPL CIRPSVVSDL KSGTNEDDLT MKLTEIIFLN DVIKKHRISG
     AKTQMIMEDW DFLQLQCALY INSELSGIPL NMAPKKWTRG FVQRLKGKQG RFRGNLSGKR
     VDFSGRTVIS PDPNLRIDEV AVPVHVAKIL TFPEKVNKAN INFLRKLVQN GPEVHPGANF
     IQQRHTQMKR FLKYGNREKM AQELKYGDIV ERHLIDGDVV LFNRQPSLHK LSIMAHLARV
     KPHRTFRFNE CVCTPYNADF DGDEMNLHLP QTEEAKAEAL VLMGTKANLV TPRNGEPLIA
     AIQDFLTGAY LLTLKDTFFD RAKACQIIAS ILVGKDEKIK VRLPPPTILK PVTLWTGKQI
     FSVILRPSDD NPVRANLRTK GKQYCGKGED LCANDSYVTI QNSELMSGSM DKGTLGSGSK
     NNIFYILLRD WGQNEAADAM SRLARLAPVY LSNRGFSIGI GDVTPGQGLL KAKYELLNAG
     YKKCDEYIEA LNTGKLQQQP GCTAEETLEA LILKELSVIR DHAGSACLRE LDKSNSPLTM
     ALCGSKGSFI NISQMIACVG QQAISGSRVP DGFENRSLPH FEKHSKLPAA KGFVANSFYS
     GLTPTEFFFH TMAGREGLVD TAVKTAETGY MQRRLVKSLE DLCSQYDLTV RSSTGDIIQF
     IYGGDGLDPA AMEGKDEPLE FKRVLDNIKA VFPCPSEPAL SKNELILTTE SIMKKSEFLC
     CQDSFLQEIK KFIKGVSEKI KKTRDKYGIN DNGTTEPRVL YQLDRITPTQ VEKFLETCRD
     KYMRAQMEPG SAVGALCAQS IGEPGTQMTL KTFHFAGVAS MNITLGVPRI KEIINASKAI
     STPIITAQLD KDDDADYARL VKGRIEKTLL GEISEYIEEV FLPDDCFILV KLSLERIRLL
     RLEVNAETVR YSICTSKLRV KPGDVAVHGE AVVCVTPREN SKSSMYYVLQ FLKEDLPKVV
     VQGIPEVSRA VIHIDEQSGK EKYKLLVEGD NLRAVMATHG VKGTRTTSNN TYEVEKTLGI
     EAARTTIINE IQYTMVNHGM SIDRRHVMLL SDLMTYKGEV LGITRFGLAK MKESVLMLAS
     FEKTADHLFD AAYFGQKDSV CGVSECIIMG IPMNIGTGLF KLLHKADRDP NPPKRPLIFD
     TNEFHIPLVT
//
